Boosting astaxanthin absorption and widening applications: Valensa releases flavorless powder format

The powder ingredient touts increased bioavailability and a shelf life of up to 24 months

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

08 May 2020 --- Valensa International’s FlexPro MD may help overcome joint deterioration thanks to its combination of krill oil, astaxanthin and hyaluronic acid. This is... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

09 Apr 2020 --- Part one of NutritionInsight’s coverage of sports nutrition revealed how COVID-19 is spurring rapid personalization, which could provide an extra... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

08 Apr 2020 --- Valensa International has received renewed United States Pharmacopeia (USP) Ingredient Verification Program for Dietary Ingredients (IVP-DI) status for its USPlus... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Mar 2020 --- US-based Cardax is seeking strategic collaborations to develop astaxanthin for the treatment of COVID-19. A new white paper from the biopharmaceutical company lays... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

04 Mar 2020 --- The European Food Safety Authority (EFSA) has reaffirmed its 2017 authorization of the use of astaxanthin-rich oleoresin from Haematococcus... Read More

trans